UPICT TEST SITE - Modified

FDG-PET/CT Draft Template - June 29, 2009

FYI: The complete draft of the QIBA FDG-PET/CT Whole Body protocol is posted at http://qibawiki.rsna.org/index.php?title=Profile:_FDG-PET_Whole_Body

1. Executive Summary, Introduction and Background Information

1.1. Principle

1.2. Indications

1.3. Relationship with other diagnostic methods

1.4. Covariates (note – please see full FDG-PET document; should this material be in other sections of the document?)

2. Claims (what users will be able to achieve)

2.1. Claim #1:

2.2. Claim #2:

2.3. Claim #3:

2.4. Claim #4:

2.5. Claim #5: (etc.)

3. Imaging Protocol: Overview

3.1. Detail: Utilities and Endpoints of the Imaging Protocol within the Clinical Trial

3.2. Detail: Management of Pre-enrollment Imaging Tests

3.3. Detail: Timing of Imaging Tests within the Clinical Trial Calendar

3.4. Detail: Management of On-protocol Imaging Performed Off-schedule

3.5. Detail: Management of Off-protocol Imaging

3.6. Detail: Subject Selection Criteria Related to Imaging (mainly exclusionary in nature)

4. Subject Preparation

4.1. Detail: Interval Timing (e.g., oral and/or IV intake, vigorous physical activity, timing relative to non-protocol-related medical interventions, etc.)

4.2. Detail: Specific Pre-imaging Instructions

4.3. Detail: Prior to Arrival

4.4. Detail: Upon Arrival (including ancillary testing associated with the imaging and downstream actions relative to such testing)

5. Imaging Procedures: General

5.1. Detail: Data that should accompany the request for a PET study

5.2. Detail: Imaging Agent Preparation and Specification (Contrast agent or radiopharmaceutical)

5.3. Detail: Contrast administration: (agent, dose, route)

5.4. Detail: Procedure for performing the PET study

5.5. Detail: Protocol alterations permitted in the case of multi-centre studies

5.6. Detail: Imaging Data Acquisition

5.7. Detail: Subject Positioning

5.8. Detail: Instructions to Subject during Acquisition (e.g., breathing)

5.9. Detail: Timing (e.g., relative to previously administered imaging agents / enhancers; inter-time point standardization)

6. Reconstruction and Reporting

6.1. Detail: Reconstruction

6.2. Detail: Reporting

6.3. Detail: Interpretation and pitfalls

7. Archival Requirements for Primary Source Imaging Data

7.1. Detail: Data should be archived in DICOM 3.0 format or the current version of DICOM recommended by XXX WG YY of the XXX.

7.2. Detail: De-identification / Anonymization Schema(s) to Be Used

7.3. Detail: Archival and Transmission of Image Data

7.4. Detail: Transmission of Imaging Data from Sites to Central Archive

7.5. Detail: Requirements for Local Retention of Imaging Data

7.6. Detail: Requirements for Central Management of Imaging Data and Imaging Metadata (e.g., the results of image analysis)

8. Post-processing (i.e., anything not done on an acquisition platform that affects DICOM image data and/or pixel / voxel values) None prior to importation into free standing image analysis software package

9. Interpretation

9.1. Detail: Image quality assessment to confirm correctness and completeness of image submission

9.2. Detail: Volume of interest (VOI) Definition

9.3. Detail: Timepoint exams defined by charter re: exam types and dates of inclusion

9.4. Detail: @Open next timepoint for given subject

10. Radiation Dose and Safety Considerations 11. Quality Control

11.1. Detail: General

11.2. Detail: Quality Control and Inter-institution Cross-Calibration

12. Required Documentation

12.1. Detail: Subject preparation

12.2. Detail: Imaging agent dose calculation

12.3. Detail: Imaging agent-related

12.4. Detail: Image data acquisition-related

12.5. Detail: Inherent image data reconstruction / processing

12.6. Detail: Image analysis and interpretation

12.7. Detail: Site selection and Quality Control

13. Acknowledgements